8-K Announcements
6Material company update
May 20, 2026·SEC
Material company update
Feb 3, 2026·SEC
Material company update
Nov 4, 2025·SEC
CorVel Corporation(CRVL)Earnings, Financials & Key Ratios
CRVL•NASDAQ•Insurance & Managed Care
27.3× P/E·Price updated Jun 19, 2026
AboutCorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.Show more
- Revenue$959M+7.0%
- Combined Ratio85.07%-1.7%
- Net Income$110M+16.0%
- Return on Equity30.81%-7.8%
- Medical Cost Ratio75.71%-1.1%
- Operating Margin14.93%+10.7%
- Net Margin11.51%+8.3%
- ROA18.56%-2.4%
- Equity / Assets61.31%+4.0%
CRVL Key Insights
CorVel Corporation (CRVL) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Profitable underwriting: 85.1% combined ratio
- ✓Excellent 3Y average ROE of 32.7%
- ✓Strong 5Y profit CAGR of 18.9%
- ✓Strong Piotroski F-Score: 7/9
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CRVL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CRVL Price & Volume
CorVel Corporation (CRVL) stock price & volume — 10-year historical chart
Loading chart...
CRVL Growth Metrics
CorVel Corporation (CRVL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.65%
5 Years11.64%
3 Years10.08%
TTM7.03%
Profit CAGR
10 Years14.49%
5 Years18.94%
3 Years18.47%
TTM15.95%
EPS CAGR
10 Years4.11%
5 Years-3.06%
3 Years19.31%
TTM16.3%
Return on Capital
10 Years32.76%
5 Years37%
3 Years38.54%
Last Year37.82%
CRVL Recent Earnings
CorVel Corporation (CRVL) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 20, 2026Metric
Actual
Est
EPS
$0.61
—
Rev
$249M
—
Q1 2026
Feb 3, 2026Metric
Actual
Est
EPS
$0.47
—
Rev
$236M
—
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.54
—
Rev
$240M
—
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.52
—
Rev
$235M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 20, 2026 | $0.61 | $249M |
| Q1 2026 | Feb 3, 2026 | $0.47 | $236M |
| Q4 2025 | Nov 4, 2025 | $0.54 | $240M |
| Q3 2025 | Aug 5, 2025 | $0.52 | $235M |
Based on last 12 quarters of dataView full earnings history →
CRVL Peer Comparison
CorVel Corporation (CRVL) competitors in Claims and cost containment services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MGRC | 2.9B | 118.19 | 18.61 | 3.65% | 16.38% | 12.84% | 0.43 | |
 GBLI | 363.66M | 25.34 | 14.48 | 2.02% | 7.45% | 0.02% | 0.01 | |
 MCRB | 63.67M | 6.61 | 10.33 | -40.89% | -127.3% | 1.88 | ||
 AMSF | 588.66M | 31.32 | 12.68 | 2.63% | 14.27% | 9.68% | 0.00 | |
 EHTH | 51.27M | 1.65 | -4.85 | 4.06% | 6.31% | 3.99% | 0.14 | |
 PINC | 2.34B | 28.26 | 128.45 | -10.86% | -2.42% | -1.59% | 0.18 | |
 MCK | 90.23B | 750.63 | 19.56 | 12.36% | 1.18% | |||
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 |
Compare CRVL vs Peers
CorVel Corporation (CRVL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CRVL Income Statement
CorVel Corporation (CRVL) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 558.35M | 595.74M | 592.23M | 552.64M | 646.23M | 718.56M | 795.31M | 895.59M | 958.53M |
Revenue Growth % | 7.65% | 6.7% | -0.59% | -6.68% | 16.93% | 11.19% | 10.68% | 12.61% | 7.03% |
Medical Costs & Claims | 451.1M | 470.93M | 466.3M | 429.02M | 494.12M | 560.3M | 623.62M | 685.86M | 725.66M |
Medical Cost Ratio % | 80.79% | 79.05% | 78.74% | 77.63% | 76.46% | 77.98% | 78.41% | 76.58% | 75.71% |
Gross Profit | 107.25M▲ 0% | 124.81M▲ 16.4% | 125.92M▲ 0.9% | 123.62M▼ 1.8% | 152.11M▲ 23.0% | 158.26M▲ 4.0% | 171.69M▲ 8.5% | 209.73M▲ 22.2% | 232.86M▲ 11.0% |
Gross Margin % | 19.21% | 20.95% | 21.26% | 22.37% | 23.54% | 22.02% | 21.59% | 23.42% | 24.29% |
Gross Profit Growth % | 2.35% | 16.37% | 0.89% | -1.82% | 23.05% | 4.04% | 8.49% | 22.15% | 11.03% |
Operating Expenses | 59.35M | 63.3M | 65.21M | 64.45M | 67.6M | 73.7M | 76.59M | 88.9M | 89.73M |
OpEx / Revenue % | 10.63% | 10.62% | 11.01% | 11.66% | 10.46% | 10.26% | 9.63% | 9.93% | 9.36% |
Depreciation & Amortization | 21.77M | 22.98M | 22.52M | 23.44M | 23.92M | 25.12M | 26.25M | 29.54M | 0 |
Combined Ratio % | 91.42% | 89.67% | 89.75% | 89.29% | 86.92% | 88.23% | 88.04% | 86.51% | 85.07% |
Operating Income | 47.9M▲ 0% | 61.51M▲ 28.4% | 60.71M▼ 1.3% | 59.17M▼ 2.5% | 84.51M▲ 42.8% | 84.55M▲ 0.0% | 95.1M▲ 12.5% | 120.82M▲ 27.0% | 143.13M▲ 18.5% |
Operating Margin % | 8.58% | 10.33% | 10.25% | 10.71% | 13.08% | 11.77% | 11.96% | 13.49% | 14.93% |
Operating Income Growth % | 0.74% | 28.41% | -1.3% | -2.53% | 42.82% | 0.05% | 12.47% | 27.05% | 18.46% |
EBITDA | 69.68M | 84.5M | 83.23M | 82.61M | 108.43M | 109.67M | 121.35M | 150.36M | 143.13M |
EBITDA Margin % | 12.48% | 14.18% | 14.05% | 14.95% | 16.78% | 15.26% | 15.26% | 16.79% | 14.93% |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 47.9M▲ 0% | 61.51M▲ 28.4% | 60.71M▼ 1.3% | 59.17M▼ 2.5% | 84.51M▲ 42.8% | 84.55M▲ 0.0% | 95.1M▲ 12.5% | 120.82M▲ 27.0% | 143.13M▲ 18.5% |
Pretax Margin % | 8.58% | 10.33% | 10.25% | 10.71% | 13.08% | 11.77% | 11.96% | 13.49% | 14.93% |
Income Tax | 12.21M | 14.81M | 13.33M | 12.82M | 18.1M | 18.19M | 18.85M | 25.66M | 32.79M |
Effective Tax Rate % | 25.48% | 24.08% | 21.96% | 21.66% | 21.42% | 21.51% | 19.82% | 21.24% | 22.91% |
Net Income | 35.7M▲ 0% | 46.7M▲ 30.8% | 47.38M▲ 1.4% | 46.36M▼ 2.2% | 66.41M▲ 43.3% | 66.36M▼ 0.1% | 76.25M▲ 14.9% | 95.17M▲ 24.8% | 110.34M▲ 16.0% |
Net Margin % | 6.39% | 7.84% | 8% | 8.39% | 10.28% | 9.24% | 9.59% | 10.63% | 11.51% |
Net Income Growth % | 21.09% | 30.84% | 1.44% | -2.16% | 43.26% | -0.07% | 14.9% | 24.8% | 15.95% |
EPS (Diluted) | 1.87▲ 0% | 2.46▲ 31.6% | 2.56▲ 4.1% | 2.50▼ 2.3% | 1.22▼ 51.2% | 1.26▲ 3.3% | 1.47▲ 16.7% | 1.83▲ 24.5% | 2.14▲ 16.9% |
EPS Growth % | 23.84% | 31.55% | 4.06% | -2.34% | -51.2% | 3.28% | 16.67% | 24.49% | 16.94% |
EPS (Basic) | 0.63 | 0.83 | 0.86 | 0.86 | 1.25 | 1.28 | 1.48 | 1.85 | 2.15 |
Diluted Shares Outstanding | 19.04M | 19.01M | 18.54M | 18.54M | 54.38M | 52.78M | 52.04M | 52.04M | 51.63M |
CRVL Balance Sheet
CorVel Corporation (CRVL) balance sheet — assets, liabilities & shareholders' equity
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 274M | 318.02M | 416.26M | 424.76M | 415.25M | 393.92M | 454.68M | 545.98M | 642.99M |
Asset Growth % | 16.41% | 16.06% | 30.89% | 2.04% | -2.24% | -5.13% | 15.42% | 20.08% | 17.77% |
Total Investment Assets | 1.08M | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 1.08M | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 163.32M | 215.49M | 208.99M | 268.94M | 264.99M | 243.77M | 302.23M | 386.69M | 462.3M |
Cash & Equivalents | 55.77M | 91.71M | 83.22M | 139.72M | 97.5M | 71.33M | 105.56M | 170.58M | 233.07M |
Receivables | 64.94M | 71.34M | 65.77M | 64.72M | 82.59M | 81.03M | 97.11M | 104.13M | 101.31M |
Other Current Assets | 35.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 115.71M |
Goodwill & Intangibles | 40.23M | 39.79M | 39.35M | 38.92M | 38.48M | 38.06M | 37.63M | 37.25M | 37.08B |
Goodwill | 36.81M | 36.81M | 36.81M | 36.81M | 36.81M | 36.81M | 36.81M | 36.81M | 36.81B |
Intangible Assets | 3.42M | 2.98M | 2.54M | 2.1M | 1.67M | 1.24M | 821K | 438K | 263M |
PP&E (Net) | 69.36M | 61.98M | 166.57M | 115.94M | 111.29M | 110.49M | 109.95M | 112.88M | 139.07M |
Other Assets | -10.91M | -11.57M | 1.35M | 345K | 481K | 1.38M | 1.32M | 454K | -37.04B |
Total Liabilities | 102.83M | 123.21M | 226.55M | 204.36M | 202.85M | 191.75M | 207.03M | 223.99M | 248.75M |
Total Debt | 0 | 0 | 98.32M | 54.66M | 43.14M | 33.76M | 31.4M | 28.08M | 20.69M |
Net Debt | -55.77M | -91.71M | 15.1M | -85.05M | -54.36M | -37.57M | -74.17M | -142.5M | -212.38M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 97.99M | 116.92M | 133.69M | 162.46M | 171.37M | 167.89M | 184.5M | 204.04M | 228.07M |
Accounts Payable | 11.79M | 9.93M | 15.14M | 12.35M | 14.08M | 15.06M | 16.41M | 15.42M | 24.55M |
Deferred Revenue | 50.81M | 62.17M | 66.64M | 79.01M | 95.58M | 107M | 118.1M | 132.28M | 0 |
Other Current Liabilities | 1.67M | -4.16M | 0 | 0 | 0 | 0 | 0 | 0 | 203.52M |
Deferred Taxes | 1000K | 1000K | 1000K | 0 | 1000K | 0 | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Equity | 171.18M▲ 0% | 194.81M▲ 13.8% | 189.71M▼ 2.6% | 220.4M▲ 16.2% | 212.4M▼ 3.6% | 202.18M▼ 4.8% | 247.65M▲ 22.5% | 321.99M▲ 30.0% | 394.23M▲ 22.4% |
Equity Growth % | 23.46% | 13.8% | -2.61% | 16.18% | -3.63% | -4.81% | 22.49% | 30.02% | 22.44% |
Shareholders Equity | 171.18M | 194.81M | 189.71M | 220.4M | 212.4M | 202.18M | 247.65M | 321.99M | 394.23M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 458.46M | 505.16M | 552.54M | 598.89M | 665.3M | 731.67M | 807.92M | 903.09M | 1.01B |
Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 5K | 5K |
Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Return on Equity (ROE) | 23.04% | 25.52% | 24.64% | 22.61% | 30.69% | 32.02% | 33.9% | 33.41% | 30.81% |
Return on Assets (ROA) | 14.01% | 15.78% | 12.9% | 11.02% | 15.81% | 16.4% | 17.97% | 19.02% | 18.56% |
Equity / Assets | 62.47% | 61.26% | 45.58% | 51.89% | 51.15% | 51.32% | 54.47% | 58.97% | 61.31% |
Debt / Equity | - | - | 0.52x | 0.25x | 0.20x | 0.17x | 0.13x | 0.09x | 0.05x |
Book Value per Share | 8.99 | 10.25 | 10.23 | 11.89 | 3.91 | 3.83 | 4.76 | 6.19 | 7.64 |
Tangible BV per Share | 6.88 | 8.16 | 8.11 | 9.79 | 3.20 | 3.11 | 4.04 | 5.47 | -710.56 |
CRVL Cash Flow Statement
CorVel Corporation (CRVL) cash flow — operating, investing & free cash flow history
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 62.15M | 78.64M | 80.83M | 94.38M | 67.22M | 82.29M | 99.24M | 127.31M | 155.64B |
Operating CF Growth % | 19.4% | 26.53% | 2.78% | 16.77% | -28.77% | 22.41% | 20.6% | 28.29% | 122147.97% |
Operating CF / Revenue % | 11.13% | 13.2% | 13.65% | 17.08% | 10.4% | 11.45% | 12.48% | 14.22% | 16237.41% |
Net Income | 35.7M | 46.7M | 47.38M | 46.36M | 66.41M | 66.36M | 76.25M | 95.17M | 110.34B |
Depreciation & Amortization | 21.77M | 22.98M | 22.52M | 23.44M | 23.92M | 25.12M | 26.25M | 29.54M | 31.76B |
Stock-Based Compensation | 3.16M | 4.35M | 4.49M | 4.98M | 5.2M | 5.56M | 4.98M | 5.71M | 5.41B |
Deferred Taxes | -874K | 1.46M | 1.47M | -8.38M | 2.3M | -1.91M | -3.32M | -5.16M | 4.78B |
Other Non-Cash Items | 3.76M | 2.18M | 1.75M | 2.61M | 280K | 1.63M | 2.12M | 3.89M | 3.34B |
Working Capital Changes | -1.37M | 966K | 3.22M | 25.37M | -30.88M | -14.47M | -7.05M | -1.83M | 2.52M |
Cash from Investing | -27.69M | -15.27M | -32.36M | -17.24M | -29.82M | -26.32M | -29.24M | -35.76M | -45.36B |
Capital Expenditures | -27.69M | -15.27M | -32.36M | -17.24M | -29.82M | -26.32M | -29.24M | -35.76M | -45.36B |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | -7.3M | -27.42M | -56.96M | -20.64M | -79.61M | -82.14M | -35.76M | -26.54M | -47.8B |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -11.19M | -35.17M | -65.61M | -32.67M | -90.08M | -93.67M | -45.71M | -37.6M | -56.21M |
Stock Issued | 3.88M | 7.74M | 0 | 0 | 0 | 0 | 0 | 0 | 8.41M |
Debt Issuance (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 3.88M | 7.74M | 8.65M | 12.03M | 10.47M | 11.53M | 9.95M | 11.07M | -47.75B |
Net Change in Cash | 27.16M▲ 0% | 35.94M▲ 32.3% | -8.49M▼ 123.6% | 56.49M▲ 765.4% | -42.21M▼ 174.7% | -26.18M▲ 38.0% | 34.23M▲ 230.8% | 65.02M▲ 89.9% | 62.49B▲ 96004.3% |
Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash at Beginning | 28.61M | 55.77M | 91.71M | 83.22M | 139.72M | 97.5M | 71.33M | 105.56M | 170.58B |
Cash at End | 55.77M | 91.71M | 83.22M | 139.72M | 97.5M | 71.33M | 105.56M | 170.58M | 233.07B |
Free Cash Flow | 34.46M▲ 0% | 63.37M▲ 83.9% | 48.47M▼ 23.5% | 77.14M▲ 59.2% | 37.4M▼ 51.5% | 55.97M▲ 49.6% | 70M▲ 25.1% | 91.56M▲ 30.8% | 110.28B▲ 120348.9% |
FCF Growth % | 64.02% | 83.86% | -23.51% | 59.15% | -51.51% | 49.64% | 25.07% | 30.81% | 120348.89% |
FCF Margin % | 6.17% | 10.64% | 8.18% | 13.96% | 5.79% | 7.79% | 8.8% | 10.22% | 11505.47% |
FCF per Share | 1.81 | 3.33 | 2.61 | 4.16 | 0.69 | 1.06 | 1.35 | 1.76 | 2.14K |
CRVL Key Ratios
CorVel Corporation (CRVL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 90.83% | 91.42% | 89.67% | 89.75% | 89.29% | 86.92% | 88.23% | 88.04% | 86.51% | 85.07% |
Medical Cost Ratio | 79.8% | 80.79% | 79.05% | 78.74% | 77.63% | 76.46% | 77.98% | 78.41% | 76.58% | 75.71% |
Return on Equity (ROE) | 21.79% | 23.04% | 25.52% | 24.64% | 22.61% | 30.69% | 32.02% | 33.9% | 33.41% | 30.81% |
Return on Assets (ROA) | 12.94% | 14.01% | 15.78% | 12.9% | 11.02% | 15.81% | 16.4% | 17.97% | 19.02% | 18.56% |
Equity / Assets | 58.9% | 62.47% | 61.26% | 45.58% | 51.89% | 51.15% | 51.32% | 54.47% | 58.97% | 61.31% |
Book Value / Share | 7.08 | 8.99 | 10.25 | 10.23 | 11.89 | 3.91 | 3.83 | 4.76 | 6.19 | 7.64 |
Debt / Equity | - | - | - | 0.52x | 0.25x | 0.20x | 0.17x | 0.13x | 0.09x | 0.05x |
Revenue Growth | 3% | 7.65% | 6.7% | -0.59% | -6.68% | 16.93% | 11.19% | 10.68% | 12.61% | 7.03% |
Related:CRVL Dividend History·CRVL Revenue History·CRVL Price History·CRVL P/E History·CRVL Financial Ratios·CRVL Institutional Holders
CRVL SEC Filings & Documents
CorVel Corporation (CRVL) SEC filings — annual & quarterly reports (10-K, 10-Q)
CRVL Frequently Asked Questions
CorVel Corporation (CRVL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
CorVel Corporation (CRVL) grew revenue by 7.0% over the past year. This is steady growth.
Yes, CorVel Corporation (CRVL) is profitable, generating $110.3M in net income for fiscal year 2026 (11.5% net margin).
Dividend & Returns
CorVel Corporation (CRVL) has a return on equity (ROE) of 30.8%. This is excellent, indicating efficient use of shareholder capital.
Industry Metrics
CorVel Corporation (CRVL) has a combined ratio of 85.1%. A ratio below 100% indicates underwriting profitability.